×
About 263 results

ALLMedicine™ Pleural Effusions Center

Research & Reviews  93 results

Subcutaneous implantable pleural port catheter in the management of malignant pleural e...
https://doi.org/10.1002/pbc.29109
Pediatric Blood & Cancer; Malterre A, Cohen-Gogo S et. al.

May 29th, 2021 - The contribution of subcutaneous implantable pleural port catheter (SIPP) for malignant pleural effusions (MPE) management in young patients with cancer, in a palliative care setting is not well explored. This monocentric series analyzed 38 patien...

Is systemic anticancer therapy associated with higher rates of malignant pleural effusi...
https://doi.org/10.1016/j.chest.2021.05.027
Chest Holling N, Patole S et. al.

May 24th, 2021 - Malignant pleural effusions (MPE) often cause symptoms and guidelines recommend early definitive intervention. However, observational data suggest systemic anti-cancer treatment (SACT) may control MPE due to certain pharmacologically-sensitive tum...

Complications of thoracoscopic talc insufflation for the treatment of malignant pleural...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097876
Journal of Cardiothoracic Surgery; Zhang W, Zhao YL et. al.

May 6th, 2021 - Talc pleurodesis is an effective treatment for malignant pleural effusions (MPEs). This study was designed to estimate complication rates of thoracoscopic talc insufflation. Literature search was conducted in electronic databases and studies were ...

Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075197
PloS One; Popowicz N, Cheah HM et. al.

Apr 27th, 2021 - Predicting survival of patients with malignant pleural effusions (MPEs) is notoriously difficult. A robust prognostic marker can guide clinical decision making. The neutrophil-to-lymphocyte ratio (NLR) in blood has been shown to predict survival i...

Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patien...
https://doi.org/10.1016/j.chest.2021.03.059
Chest Molina S, Martinez-Zayas G et. al.

Apr 15th, 2021 - Evidence-based guidelines recommend management strategies for malignant pleural effusions (MPEs) based on life expectancy. Existent risk-prediction rules do not provide precise individualized survival estimates. Can a newly developed continuous ri...

see more →

Guidelines  1 results

ERS/EACTS statement on the management of malignant pleural effusions.
https://doi.org/10.1183/13993003.00349-2018
The European Respiratory Journal; Bibby AC, Dorn P et. al.

Jul 29th, 2018 - Malignant pleural effusions (MPE) are a common pathology, treated by respiratory physicians and thoracic surgeons alike. In recent years, several well-designed randomised clinical trials have been published that have changed the landscape of MPE m...

see more →

Clinicaltrials.gov  10 results

Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality Models
https://clinicaltrials.gov/ct2/show/NCT03656822

Feb 6th, 2020 - This early phase I trial studies how well indwelling pleural catheters with doxycycline work compared to indwelling pleural catheters alone in treating participants with malignant pleural effusions. These types of catheters are commonly used to tr...

Using Pleural Effusions to Diagnose Cancer
https://clinicaltrials.gov/ct2/show/NCT03319472

Dec 10th, 2019 - Background: Pleural effusions (PE) are common conditions that signal either pleural-disseminated infection or cancer. While these diagnoses bear tremendous importance for patients, they require invasive procurement of pleural tissues and/or cells ...

Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
https://clinicaltrials.gov/ct2/show/NCT03661801

Jul 26th, 2019 - A prospective observation study examining the clinical utility of novel pleural fluid, biopsy and serum biomarkers for the investigation of pleural effusions (INVEST). The INVEST study will collect blood, pleural fluid and tissue samples from dono...

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
https://clinicaltrials.gov/ct2/show/NCT00066404

Mar 13th, 2019 - OBJECTIVES: Determine the safety and toxicity of intrapleural BG00001 in patients with malignant pleural mesothelioma or malignant pleural effusions. Determine the maximum tolerated dose of this drug in these patients. Determine the success of gen...

The Experiences of Patients Living With Malignant Pleural Effusions
https://clinicaltrials.gov/ct2/show/NCT03235999

Aug 2nd, 2018 - Up to 20 patients with malignant pleural effusions will be interviewed about their experiences of having this condition and its management.

see more →

News  1 results

Cardiovascular Medicine and Surgery NetWork
https://www.mdedge.com/chestphysician/article/214641/society-news/cardiovascular-medicine-and-surgery-network/page/0/1?channel=28399

Jan 17th, 2020 - Clinical pulmonary medicine Definitive pleural interventions in malignant pleural effusions Malignant pleural effusions (MPEs) contribute significantly to symptom burden, and an emphasis on patient-centered outcomes prioritizes palliation of sympt.

see more →